AI-ECG Platform vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Carewell Health
VS
by eMurmur

AI Verdict

The AI-ECG Platform focuses on AI-powered analysis of 12-lead resting ECGs for diagnosing electrical abnormalities and structural changes of the heart. In contrast, eMurmur Heart AI specializes in AI-driven analysis of heart and lung sounds from auscultation to detect murmurs and provide hemodynamic insights. While both tools leverage AI for cardiovascular assessment and share common specialties like Cardiology and Internal Medicine, they utilize distinct diagnostic modalities, making them complementary rather than direct competitors.

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your primary need is highly accurate, rapid, and automated interpretation of 12-lead resting ECGs. This tool is ideal for physicians who require AI assistance in diagnosing specific cardiovascular diseases like arrhythmias, myocardial ischemia, or infarction, integrating seamlessly with existing ECG machine infrastructure.

View AI-ECG Platform →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if your focus is on leveraging AI for automated analysis of heart and lung sounds, particularly for detecting murmurs and gaining hemodynamic insights. This platform is well-suited for clinicians engaged in screening, continuous monitoring, or remote consultation, especially when utilizing digital stethoscopes and requiring mobile or web-based access.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Platform eMurmur Heart AI
Pricing Unknown Contact for quote
Deployment On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client). Web-based, Mobile App, API integration
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI offers broader accessibility with its mobile app (iOS, Android) and web portal, facilitating live streaming and remote auscultation for telehealth. While AI-ECG Platform provides workstation and web-based options, eMurmur's mobile-first approach and hardware-neutral compatibility enhance its versatility for various point-of-care and remote clinical workflows.

Clinical Value

AI-ECG Platform

Both tools are FDA-cleared and clinically validated. AI-ECG Platform boasts over 95% accuracy in diagnosing major cardiovascular diseases, including complex conditions like myocardial infarction and ventricular hypertrophy, based on 12-lead ECG interpretation. While eMurmur Heart AI offers valuable screening for heart and lung sounds, AI-ECG's depth and high accuracy in diagnosing specific cardiac pathologies provide a stronger diagnostic clinical value.

Pricing & Value

Tie

Both AI-ECG Platform and eMurmur Heart AI require direct contact for pricing information. Without transparent pricing details or comparative cost-benefit analyses, it is impossible to determine which tool offers better value.

Enterprise Readiness

eMurmur Heart AI

eMurmur Heart AI explicitly states HIPAA and GDPR compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption and data security. Although AI-ECG Platform supports various ECG data formats for integration, its compliance claims are not explicitly confirmed in the provided information.

Innovation

eMurmur Heart AI

eMurmur Heart AI demonstrates greater innovation by extending AI analysis to both heart and lung sounds, providing hemodynamic insights, and integrating robust telehealth features like live streaming and remote auscultation. Its hardware-neutral and stethoscope-agnostic design, along with the ability to compare longitudinal data, showcases a more expansive application of AI in a broader diagnostic and monitoring context.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered specific details regarding the availability, quality, or comprehensiveness of support services or documentation for either AI-ECG Platform or eMurmur Heart AI. Therefore, a definitive comparison cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Platform eMurmur Heart AI
Name AI-ECG Platform eMurmur Heart AI
Company Shenzhen Carewell Electronics Co., Ltd. CSD Labs
Primary Analysis Focus 12-lead resting ECG Heart and lung sounds
Key Diagnostic Capabilities AI-powered automatic ECG analysis and diagnosis; diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; over 95% accuracy in diagnosing major cardiovascular diseases. Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes); detection and classification of pathologic and innocent heart murmurs; hemodynamic insights.
Specialties Supported Cardiology, Emergency Medicine, Internal Medicine Cardiology, Internal Medicine, Pulmonology
Hardware Compatibility Hardware independent, compatible with most ECG machines Hardware-neutral and stethoscope agnostic platform compatibility

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Platform and eMurmur Heart AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Platform is designed for the automated analysis and diagnosis of 12-lead resting ECGs, assisting physicians in identifying conditions such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. In contrast, eMurmur Heart AI focuses on the AI-powered analysis of heart and lung sounds, detecting murmurs (pathologic and innocent), crackles, and wheezes, and providing hemodynamic insights.
The AI-ECG Platform is hardware independent and compatible with most ECG machines, offering deployment via a workstation, web-based portal, or Windows-based diagnostic client. eMurmur Heart AI is hardware-neutral and stethoscope agnostic, supporting digital stethoscopes and accessible through a cloud-based web application and mobile app.
The AI-ECG Platform assists in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with over 95% accuracy. eMurmur Heart AI detects and classifies pathologic and innocent heart murmurs, along with lung sounds like crackles and wheezes, and offers hemodynamic insights such as loudness ratios of S1, systole, S2, and diastole.
eMurmur Heart AI explicitly supports telehealth with features like live streaming and remote auscultation, as well as mobile app access for remote consultation and monitoring. While the AI-ECG Platform offers a web-based management portal and diagnostic client for review, it does not explicitly detail live remote patient interaction for ECG acquisition.
The AI-ECG Platform supports various ECG data formats for integration, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG.
The AI-ECG Platform provides rapid diagnosis in approximately 3 seconds. eMurmur Heart AI does not explicitly state a processing speed in the provided information, but it is designed for automated analysis of recorded heart sounds.
AI Tool Finder
AI-powered search. Results may not be comprehensive.